- Joined
- Aug 7, 2008
- Messages
- 1,125
- Points
- 38
How can this be something to be rpoud of. This is disturbing news.
Singaporeans are good for HUMAN GUINEA PIGS!
http://www.straitstimes.com/BreakingNews/Singapore/Sto
ry/STIStory_470482.html
EFFORTS to draw drug companies here to conduct trials for new medicines are paying off, with a record 286 trials started last year.
Since 2004, the Health Sciences Authority (HSA) has approved 200 or more new trials every year, involving 2,000 to 3,000 people altogether.
One in three of last year's record haul of trials was for cancer treatment, reflecting the focus of big pharmaceutical research in recent years. Others included drugs for heart, eye, gut and brain problems.
Doctors initiate just a quarter of trials here, with drug companies behind the rest.
The companies need the findings of the trials to be accepted by health authorities in the United States and in Europe, where patients' buying power makes the US$1 billion (S$1.4 billion) spent in developing a new drug worthwhile.
Professor Soo Khee Chee, head of the National Cancer Centre (NCC), says that drug companies are increasingly drawn to Singapore because of the high standards of medical practice, technological expertise, and government support, which mean that trials can be conducted with speed and efficiency.
[email protected]
Singaporeans are good for HUMAN GUINEA PIGS!
http://www.straitstimes.com/BreakingNews/Singapore/Sto
ry/STIStory_470482.html
EFFORTS to draw drug companies here to conduct trials for new medicines are paying off, with a record 286 trials started last year.
Since 2004, the Health Sciences Authority (HSA) has approved 200 or more new trials every year, involving 2,000 to 3,000 people altogether.
One in three of last year's record haul of trials was for cancer treatment, reflecting the focus of big pharmaceutical research in recent years. Others included drugs for heart, eye, gut and brain problems.
Doctors initiate just a quarter of trials here, with drug companies behind the rest.
The companies need the findings of the trials to be accepted by health authorities in the United States and in Europe, where patients' buying power makes the US$1 billion (S$1.4 billion) spent in developing a new drug worthwhile.
Professor Soo Khee Chee, head of the National Cancer Centre (NCC), says that drug companies are increasingly drawn to Singapore because of the high standards of medical practice, technological expertise, and government support, which mean that trials can be conducted with speed and efficiency.
[email protected]